BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ye JZ, Chen JZ, Li ZH, Bai T, Chen J, Zhu SL, Li LQ, Wu FX. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion. World J Gastroenterol 2017; 23(41): 7415-7424 [PMID: 29151695 DOI: 10.3748/wjg.v23.i41.7415]
URL: https://www.wjgnet.com/1948-5182/full/v23/i41/7415.htm
Number Citing Articles
1
Zhen Li, Du Xiao, Xin Li, Pengchao Zhan, Jiaxiang Wang, Henghui Zhang. Early recurrence detected in hepatocellular carcinoma patients after transcatheter arterial chemoembolization treatment with plasma cell-free DNAEuropean Journal of Gastroenterology & Hepatology 2019; 31(7): 885 doi: 10.1097/MEG.0000000000001373
2
Zhen-Hua Chen, Xiu-Ping Zhang, Jin-Kai Feng, Le-Qun Li, Fan Zhang, Yi-Ren Hu, Cheng-Qian Zhong, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Wan Yee Lau, Shu-Qun Cheng. Actual long-term survival in hepatocellular carcinoma patients with microvascular invasion: a multicenter study from ChinaHepatology International 2021; 15(3): 642 doi: 10.1007/s12072-021-10174-x
3
Wenlong Song, Xiangling Yu, Dajing Guo, Huan Liu, Zhuoyue Tang, Xinjie Liu, Jun Zhou, Haiping Zhang, Yangyang Liu, Xi Liu. MRI‐Based Radiomics: Associations With the Recurrence‐Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial ChemoembolizationJournal of Magnetic Resonance Imaging 2020; 52(2): 461 doi: 10.1002/jmri.26977
4
Derek J. Erstad, Kenneth K. Tanabe. ASO Author Reflections: A New Look at the Clinical Significance of MVI in Hepatocellular CarcinomaAnnals of Surgical Oncology 2019; 26(S3): 617 doi: 10.1245/s10434-019-07364-1
5
Lei Wang, Qiao Ke, Kongying Lin, Jingbo Chen, Ren Wang, Chunhong Xiao, Xiaolong Liu, Jingfeng Liu. <p>Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study</p>Cancer Management and Research 2020; : 3815 doi: 10.2147/CMAR.S251605
6
Shuang Liu, Hui Li, Lei Guo, Bo Zhang, Binghai Zhou, Wentao Zhang, Jian Zhou, Jia Fan, Qinghai Ye. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular InvasionThe Oncologist 2019; 24(4): 513 doi: 10.1634/theoncologist.2018-0305
7
Zhen-Hua Chen, Xiu-Ping Zhang, Hang Wang, Zong-Tao Chai, Ju-Xian Sun, Wei-Xing Guo, Jie Shi, Shu-Qun Cheng. Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysisHPB 2019; 21(8): 935 doi: 10.1016/j.hpb.2019.02.003
8
Lei Liang, Chao Li, Yong-Kang Diao, Hang-Dong Jia, Hao Xing, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Dong-Sheng Huang, Cheng-Wu Zhang, Tian Yang. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysisTherapeutic Advances in Gastroenterology 2020; 13: 175628482097769 doi: 10.1177/1756284820977693
9
Xizhu Xu, Rui Chen, Qingmei Chen, Kang An, Lu Ding, Le Zhang, Fang Wang, Yang Deng. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective studyComplementary Therapies in Clinical Practice 2021; 43: 101359 doi: 10.1016/j.ctcp.2021.101359
10
Han Wang, Meng‐Chao Wu, Wen‐Ming Cong. Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysisHepatology Research 2019; 49(3): 344 doi: 10.1111/hepr.13241
11
Ai Shen, Miao Liu, Daofeng Zheng, Qingsong Chen, Zhongjun Wu. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysisClinics and Research in Hepatology and Gastroenterology 2020; 44(2): 142 doi: 10.1016/j.clinre.2019.06.012
12
Yunyun Wei, Wei Pei, Yunying Qin, Danke Su, Hai Liao. Preoperative MR imaging for predicting early recurrence of solitary hepatocellular carcinoma without microvascular invasionEuropean Journal of Radiology 2021; 138: 109663 doi: 10.1016/j.ejrad.2021.109663
13
Shu‐Wen Sun, Qiu‐Ping Liu, Xun Xu, Fei‐Peng Zhu, Yu‐Dong Zhang, Xi‐Sheng Liu. Direct Comparison of Four Presurgical Stratifying Schemes for Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Gadoxetic Acid‐Enhanced MRIJournal of Magnetic Resonance Imaging 2020; 52(2): 433 doi: 10.1002/jmri.27043
14
Xiu-Ping Zhang, Yan-Chen Liu, Zhen-Hua Chen, Ju-Xian Sun, Kang Wang, Zong-Tao Chai, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Wan Yee Lau, Shu-Qun Cheng. Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching AnalysisAnnals of Surgical Oncology 2019; 26(5): 1465 doi: 10.1245/s10434-019-07223-z
15
Ana-Maria Ciurea, Dan Ionuț Gheonea, Michael Schenker, Alina Maria Mehedințeanu, Georgică Costinel Târtea, Cristin Constantin Vere. The Prognostic Correlation of Heart Rate Variability at Diagnosis with Survival of Patients with Hepatocellular CarcinomaDiagnostics 2021; 11(5): 890 doi: 10.3390/diagnostics11050890
16
Shinichiro Nakada, Marc-Antoine Allard, Maite Lewin, Sameh Awad, Nour Dahbi, Hidetoshi Nitta, Antonio Sa Cunha, Denis Castaing, Eric Vibert, Daniel Cherqui, Masaru Miyazaki, Masayuki Ohtsuka, René Adam. Ischemic Cholangiopathy Following Transcatheter Arterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy: an Underestimated and Devastating ComplicationJournal of Gastrointestinal Surgery 2020; 24(11): 2517 doi: 10.1007/s11605-019-04409-4
17
Feng-Yong Liu, Xin Li, Hong-Jun Yuan, Yang Guan, Mao-Qiang Wang. Angio-Computed Tomograph-Guided Immediate Lipiodol Computed Tomograph for Diagnosis of Small Hepatocellular Carcinoma Lesions during Transarterial ChemoembolizationChinese Medical Journal 2018; 131(20): 2410 doi: 10.4103/0366-6999.243554
18
Liang Sun, Pi-Bao Li, Yan-Fen Yao, Ai-Yuan Xiu, Zhi Peng, Yu-Huan Bai, Yan-Jing Gao. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinomaWorld Journal of Gastroenterology 2018; 24(10): 1120-1133 doi: 10.3748/wjg.v24.i10.1120
19
Clifford Akateh, Sylvester M Black, Lanla Conteh, Eric D Miller, Anne Noonan, Eric Elliott, Timothy M Pawlik, Allan Tsung, Jordan M Cloyd. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(28): 3704-3721 doi: 10.3748/wjg.v25.i28.3704
20
Xiu-Ping Zhang, Zong-Tao Chai, Yu-Zhen Gao, Zhen-Hua Chen, Kang Wang, Jie Shi, Wei-Xing Guo, Teng-Fei Zhou, Jin Ding, Wen-Ming Cong, Dong Xie, Wan Y. Lau, Shu-Qun Cheng. Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysisHPB 2019; 21(12): 1687 doi: 10.1016/j.hpb.2019.04.014
21
Soon Kyu Lee, Myeong Jun Song, Seok Hwan Kim, Misun Park, Ming-Lung Yu. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort studyPLOS ONE 2019; 14(5): e0216173 doi: 10.1371/journal.pone.0216173
22
Tongshan Wang, Jun Liu, Suihui Li, Zhengang Yuan, Xiangzhong Huang. Effects of knockout of lincRNA‑p21 on the proliferation, migration and invasion ability of HepG2 liver cancer cellsOncology Letters 2019;  doi: 10.3892/ol.2019.10201
23
Han Wang, Hua Yu, You-Wen Qian, Zhen-Ying Cao, Meng-Chao Wu, Wen-Ming Cong. Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2021; 20(3): 232 doi: 10.1016/j.hbpd.2020.12.018
24
Liang Xiao, Furong Zeng, Guangtong Deng. Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinomaBioscience Reports 2019; 39(10) doi: 10.1042/BSR20190683
25
Andrew K.Y. Fung, Nicole M.Y. Cheng, Charing C.N. Chong, Kit-Fai Lee, John Wong, Sunny Y.S. Cheung, Hon-Ting Lok, Paul B.S. Lai, Kelvin K.C. Ng. Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomyMedicine 2020; 99(48): e23358 doi: 10.1097/MD.0000000000023358
26
Wen Chen, Tao Ma, Jian Zhang, Xiaozhen Zhang, Wei Chen, Yinan Shen, Xueli Bai, Tingbo Liang. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinomaHPB 2020; 22(6): 795 doi: 10.1016/j.hpb.2019.12.013
27
Zehao Zheng, Renguo Guan, Wang Jianxi, Zhen Zhao, Tianyi Peng, Chunsheng Liu, Ye Lin, Zhixiang Jian, Yuan Seng Wu. Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive ManagementJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/9567041
28
Lian Li, Bo Li, Ming Zhang. Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysisActa Radiologica 2020; 61(6): 723 doi: 10.1177/0284185119878357
29
Qiao Ke, Fu Xiang, Chunhong Xiao, Qizhen Huang, Xiaolong Liu, Yongyi Zeng, Lei Wang, Jingfeng Liu. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolizationBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08843-z
30
Xiu-Ping Zhang, Kang Wang, Xu-Biao Wei, Le-Qun Li, Hui-Chuan Sun, Tian-Fu Wen, Zong-Tao Chai, Zhen-Hua Chen, Jie Shi, Wei-Xing Guo, Dong Xie, Wen-Ming Cong, Meng-Chao Wu, Wan Yee Lau, Shu-Qun Cheng. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter StudyThe Oncologist 2019; 24(12): e1476 doi: 10.1634/theoncologist.2018-0868
31
Xue-Fen Lei, Yang Ke, Tian-Hao Bao, Hao-Ran Tang, Xue-Song Wu, Zhi-Tian Shi, Jie Lin, Zhi-Xian Zhang, Hou Gu, Lin Wang. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative studyWorld Journal of Clinical Cases 2018; 6(5): 74-83 doi: 10.12998/wjcc.v6.i5.74
32
Maria Tampaki, George Vasileios Papatheodoridis, Evangelos Cholongitas. Intrahepatic recurrence of hepatocellular carcinoma after resection: an updateClinical Journal of Gastroenterology 2021; 14(3): 699 doi: 10.1007/s12328-021-01394-7
33
Lei Wang, Qiao Ke, Nanping Lin, Yongyi Zeng, Jingfeng Liu. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysisScandinavian Journal of Gastroenterology 2019; 54(5): 528 doi: 10.1080/00365521.2019.1610794
34
Xiulin Xiao, Lin Zhou, Long Zhang, Zhiyuan Xu, Qixin Dai, Xiaohong Deng, Weiguo Li. Short-Term and Long-Term Curative Effect of Partial Hepatectomy on Ruptured Hemorrhage of Primary Liver Cancer after TAEEmergency Medicine International 2022; 2022: 1 doi: 10.1155/2022/2484418
35
Qizhen Huang, Kongying Lin, Lei Wang, Jianxing Zeng, Hongzhi Liu, Zongren Ding, Yongyi Zeng, Jingfeng Liu. <p>Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study</p>Cancer Management and Research 2020; : 9183 doi: 10.2147/CMAR.S270467
36
Shang-Dong Qin, Jie Zhang, Ya-Peng Qi, Jian-Hong Zhong, Bang-De Xiang. Individual and joint influence of cytokeratin 19 and microvascular invasion on the prognosis of patients with hepatocellular carcinoma after hepatectomyWorld Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02632-z
37
Guifang Zeng, Baojia Zou, Yongliang Li, En Lin, Xialei Liu, Peiping Li, Jiafan Chen, Baimeng Zhang, Yingbin Jia, Chaonong Cai, Jian Li. Efficacy of Adjuvant Transarterial Chemoembolization after Radical Hepatectomy in Solitary Hepatocellular Carcinoma Patients: A Retrospective StudyJournal of Investigative Surgery 2022; 35(6): 1208 doi: 10.1080/08941939.2021.2021334
38
Yanan Jiang, Xiuyun Shen, Moyondafoluwa Blessing Fasae, Fengnan Zhi, Lu Chai, Yue Ou, Hai Feng, Siwei Liu, Ying Liu, Shucai Yang, Maria Isaguliants. The Expression and Function of Circadian Rhythm Genes in Hepatocellular CarcinomaOxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/4044606
39
Juqiang Zhang, Hao Peng, Botian Wang, Lei Luo, Yuan Cheng, Guolin He, Yujun Tang, MingXin Pan. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor CellJournal of Gastrointestinal Surgery 2021; 25(7): 1770 doi: 10.1007/s11605-020-04755-8
40
Yong Zhu He, Kun He, Rui Qin Huang, Ze Liang Wang, Shao Wei Ye, Li Wen Liu, Qi Jie Luo, Ze Min Hu. Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysisAnnals of Hepatology 2020; 19(6): 654 doi: 10.1016/j.aohep.2020.07.002
41
Lian Li, Bo Li, Ming Zhang. HBV DNA levels impact the prognosis of hepatocellular carcinoma patients with microvascular invasionMedicine 2019; 98(27): e16308 doi: 10.1097/MD.0000000000016308
42
Zhen-Hua Chen, Xiu-Ping Zhang, Jin-Kai Feng, Le-Qun Li, Fan Zhang, Yi-Ren Hu, Cheng-Qian Zhong, Kang Wang, Zong-Tao Chai, Xu-Biao Wei, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Wan Y. Lau, Shu-Qun Cheng. Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from ChinaHPB 2022; 24(7): 1063 doi: 10.1016/j.hpb.2021.11.016
43
Jiarui Yang, Hao Liang, Kunpeng Hu, Zhiyong Xiong, Mingbo Cao, Zhaozhong Zhong, Zhicheng Yao, Meihai Deng. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysisCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01790-6
44
Derek J. Erstad, Kenneth K. Tanabe. Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular CarcinomaAnnals of Surgical Oncology 2019; 26(5): 1474 doi: 10.1245/s10434-019-07227-9
45
Zhen-Hua Chen, Xiu-Ping Zhang, Teng-Fei Zhou, Kang Wang, Hang Wang, Zong-Tao Chai, Jie Shi, Wei-Xing Guo, Shu-Qun Cheng. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysisEuropean Journal of Surgical Oncology 2019; 45(11): 2188 doi: 10.1016/j.ejso.2019.06.031
46
Kevin P. Labadie, Jonathan G. Sham. Adjuvant Transcatheter Arterial Infusion Therapy for Hepatocellular Carcinoma: Not Yet for EverybodyAnnals of Surgical Oncology 2020; 27(11): 4070 doi: 10.1245/s10434-020-08702-4
47
Naoya Sato, Shigeru Marubashi. What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection?Surgery Today 2022; 52(6): 871 doi: 10.1007/s00595-021-02352-z
48
Zhan-Qi Wei, Yue-Wei Zhang. Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma: a focus on its controversies and screening of patients most likely to benefitChinese Medical Journal 2021; 134(19): 2275 doi: 10.1097/CM9.0000000000001767
49
Chao Li, Ming-Da Wang, Lun Lu, Han Wu, Jiong-Jie Yu, Wan-Guang Zhang, Timothy M. Pawlik, Yao-Ming Zhang, Ya-Hao Zhou, Wei-Min Gu, Hong Wang, Ting-Hao Chen, Jun Han, Hao Xing, Zhen-Li Li, Wan Yee Lau, Meng-Chao Wu, Feng Shen, Tian Yang. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysisHepatology International 2019; 13(6): 736 doi: 10.1007/s12072-019-09981-0